Indications
Ziconotide is indicated for the treatment of severe, chronic pain in patients who require intrathecal (IT) analgesia.
Composition
- Active substance
- ziconotide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Prialt
- Active substance
- ziconotide
- ATC code
- N02BG08
- Group
- Nervous system
- Therapeutic area
- Injections, Spinal, Pain
- Marketing authorisation holder
- Esteve Pharmaceuticals GmbH
- Status
- Authorised
- EU authorisation
- 21 Feb 2005
- EMA product number